The Institute for Clinical and Economic Review (ICER) is ultimately deciding which lives are worth saving through its value frameworks and drug pricing assessments, the author of a recent opinion article published in the Orange County Register writes.
“If you are an Orange County resident living with a life-threatening or chronic disease, such as cancer, cystic fibrosis, arthritis, or many others, ICER’s formula is likely to determine that your life is worth less than that of a healthy person,” the article’s author, Neuropathy Action Foundation board member Chris Buchanan, writes.
The Neuropathy Action Foundation is a patient advocacy organization based in of Orange County.
Buchanan writes there is “little transparency” in ICER’s model which ultimately “means other researchers are unable to analyze and replicate” the organization’s results.
ICER on its website hails itself as a “non-partisan research organization that objectively evaluates the clinical and economic value of prescription drugs, medical tests, and other health care and health care delivery innovations.”